Irinotecan liposome injection with oxaliplatin, 5-fluorouracil and leucovorin for previously untreated metastatic pancreatic cancer

Irinotecan liposome injection with oxaliplatin, 5-fluorouracil and leucovorin is in development for the treatment of metastatic pancreatic cancer. Pancreatic cancer occurs when abnormal cells in the pancreas divide and grow in an uncontrolled way, forming a growth (tumour). Cells from the tumour can spread to other parts of the body (metastases). Metastatic pancreatic cancer has a poor prognosis, due to late diagnosis, and it cannot be cured. Treatment for metastatic pancreatic cancer aims to control the symptoms and increase survival time.